Advertisement
New Zealand markets closed

  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     

  • NZD/USD

    0.5894
    -0.0011 (-0.19%)
     

  • NZD/EUR

    0.5531
    -0.0013 (-0.24%)
     

  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     

  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     

  • OIL

    83.05
    +0.32 (+0.39%)
     

  • GOLD

    2,399.90
    +1.90 (+0.08%)
     

  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     

  • FTSE

    7,818.71
    -58.34 (-0.74%)
     

  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     

  • DAX

    17,669.55
    -167.85 (-0.94%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • NZD/JPY

    91.0230
    -0.2310 (-0.25%)
     

Flow Cytometry in Oncology and Immunology Global Market Report 2022: Innovation in Flow Cytometry Leading to Use of Next-Generation Flow Cytometers

Research and Markets
Updated ·3-min read
Company Logo
Company Logo

Global Flow Cytometry in Oncology Market

Global Flow Cytometry in Oncology Market
Global Flow Cytometry in Oncology Market

Dublin, Nov. 29, 2022 (GLOBE NEWSWIRE) -- The "Flow Cytometry in Oncology and Immunology Market - A Global Market and Regional: Focus on Offering, Technology, End User, Type, Application, and Country - Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering.

The global flow cytometry in oncology and immunology market was valued at $1,653.2 million in 2021 and is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032. The market is driven by factors such as the increasing burden of cancer, expansion of applications in flow cytometry for research activities, innovation in flow cytometry leading to the use of next-generation flow cytometers, and the increasing use of flow cytometry in the identification and diagnosis of immune-deficiency diseases.

ADVERTISEMENT

Market Lifecycle Stage

The global flow cytometry in the oncology and immunology market is in the developed phase. The increasing research for flow cytometry for the detection of solid tumors and the leveraging of public-private initiatives to advance R&D in the field of immunology and oncology research are some of the major opportunities in the global flow cytometry in oncology and immunology market.

Market Segmentation

Segmentation 1: by Offering

  • Products

  • Services

Segmentation 2: by Technology

  • Cell-Based Flow Cytometry

  • Bead-Based Flow Cytometry

Segmentation 3: by Type

  • Immunology

  • Oncology

Segmentation 4: by Application

  • Translational Research

  • Clinical Research

Segmentation 5: by End User

  • Hospitals, Diagnostic Laboratories, and Reference Laboratories

  • Pharmaceutical and Biotechnology Companies

  • Academic Research Institutes

  • Contract Research Organizations

  • Others

Segmentation 6: by Region

  • North America - U.S., Canada

  • Europe - Germany, France, U.K., Italy, Spain, Netherlands, Rest-of-Europe

  • Asia-Pacific - Japan, China, India, Australia, South Korea, Singapore, Rest-of-Asia-Pacific

  • Latin America - Brazil, Mexico, Rest-of-Latin America

  • Rest-of-the-World

Demand - Drivers and Limitations

Following are the drivers for the global flow cytometry in oncology and immunology market:

  • Increasing Burden of Cancer is One of the Major Propelling Factors for the Innovation of Novel Technologies in Flow Cytometry

  • Expansion of Applications in Flow Cytometry for Research Activities Propels its Demand in the Market

  • Innovation in Flow Cytometry Leading to Use of Next-Generation Flow Cytometers

  • Increasing Use of Flow Cytometry in Identification and Diagnosis of Immune-Deficiency Diseases

The market is expected to face some limitations as well due to the following challenges:

  • High Cost of the Products of the Flow Cytometry Equipment Restraining the Adoption of the Devices in Emerging Economies

  • False Negative and Positive Antibody Responses Can Hinder the Adoption of Flow Cytometry

Key Market Players and Competition Synopsis

  • Agilent Technologies, Inc.

  • Becton, Dickinson and Company

  • Bio-Rad Laboratories, Inc.

  • Cell Signaling Technology, Inc.

  • Cytek Biosciences, Inc.

  • Danaher Corporation

  • DiaSorin S.p.A (Luminex Corporation)

  • Enzi Biochem Inc.

  • Laboratory Corporation of America Holdings

  • Merck KGaA

  • Miltenyi Biotec

  • NeoGenomics Laboratories, Inc.

  • OPKO Health, Inc.

  • Sony Group Corporation

  • Thermo Fisher Scientific Inc.

Key Topics Covered:

1 Markets

2 Industry Insights

3 Global Flow Cytometry in Oncology and Immunology Market (by Technology)

4 Global Flow Cytometry in Oncology and Immunology Market (by Offering)

5 Global Flow Cytometry in Oncology and Immunology Market (by Application)

6 Global Flow Cytometry in Oncology and Immunology Market (by Type)

7 Global Flow Cytometry in Oncology and Immunology Market (by End User)

8 Region

9 Competitive Benchmarking & Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/kpcxi

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900